News and Announcements
Credi Continues Expansion to NZ
- Published December 06, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Credi continues their international expansion as the platform is now available in NZ.
- This comes after a successful market test of 2 months that saw over 100 users join the “Bank of Mum and Dad.”
- There have been $50 million dollars of loans over a 6 month period through the platform.
Credi Pty Ltd, a world-first relationship-lending platform that empowers “The Bank of Mum and Dad”, continues their growth into international markets with the availability of the platform in New Zealand.
After a successful market test that was conducted for 2 months, the platform secured over 100 users, displaying the need for the Credi platform in NZ.
The demand for the formalising of agreements is high as this confirms the terms of the agreement and reduces the risk between the loaning parties. With the “Bank of Mum and Dad” becoming increasingly popular for loans for property and cars, to holidays and laptops.
There is a strong demand Credi have uncovered in sharing between partners for finance professionals. Currently, the platform only facilitates sharing between individuals, however, Credi has intentions to release a partner version in the coming weeks.
About Credi Pty Ltd
If you’ve ever loaned your children money you are officially a branch manager of “The Bank of Mum and Dad”. You are also a part of one of the fast-growing sectors of the Australian economy. Credi.com was born out of the pressing need to document loans between family members, friends and businesses. It removes the stress, the embarrassment and the risk of legal action, formalising a loan within minutes and without a scrap of costly, time-consuming paperwork.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
